参考文献/References:
[1] Ackerman MH,Ahrens T,Kelly J,et al. Sepsis[J]. Crit Care Nurs Clin North Am,2021,33(4):407-418.
[2] Minderhoud TC,Azijli K,Nanayakkara PWB. Sepsis[J]. Lancet,2020,396(10265):1804.
[3] Fleischmann C,Scherag A,Adhikari NK,et al. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations[J]. Am J Respir Crit Care Med,2016,193(3):259-272.
[4] Jensen IJ,Sjaastad FV,Griffith TS,et al. Sepsis-induced t cell immunoparalysis: the ins and outs of impaired t cell immunity[J]. J Immunol,2018,200(5):1543-1553.
[5] de Backer D,Dorman T. Surviving sepsis guidelines: a continuous move toward better care of patients with sepsis[J].?JAMA,2017,317(8):807-808.
[6] Vardakas KZ,Voulgaris GL,Maliaros A,et al. Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials[J].?Lancet Infect Dis,2018,18(1):108-120.
[7] Kheterpal S,Singh K,Topol EJ. Digitising the prediction and management of sepsis[J]. Lancet,2022,399(10334):1459.
[8] An R,Zhao L,Xi C,et al. Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism[J]. Basic Res Cardiol,2016,111(1):8.
[9] Rhodes A,Evans LE,Alhazzani W,et al. Surviving sepsis campaign: international Guidelines for management of sepsis and septic shock: 2016[J]. Crit Care Med,2017,45(3):486-552.
[10] Hunter JD,Doddi M. Sepsis and the heart[J].?Br J Anaesth,2010,104(1):3-11.
[11] Bouhemad B,Nicolas-Robin A,Arbelot C,et al. Isolated and reversible impairment of ventricular relaxation in patients with septic shock[J].?Crit Care Med,2008,36(3):766-774.
[12] Vandebergh M,Dubois B,Goris A,et al. Effects of vitamin D and body mass index on disease risk and relapse hazard in multiple sclerosis: a mendelian randomization study[J].Neurol Neuroimmunol Neuroinflamm,2022,9(3):e1165.
[13] Davies NM,Holmes MV,Davey Smith G. Reading Mendelian randomisation studies:a guide,glossary,and checklist for clinicians[J]. BMJ,2018,362:k601.
[14] Shah S,Henry A,Roselli C,et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure[J].?Nat Commun,2020,11(1):163.
[15] Maciejewski ML,Dowd BE,Norton EC. Instrumental variables and heterogeneous treatment effects[J] . JAMA,2022,327(12):1177-1178.
[16] Sanderson E,Spiller W,Bowden J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization[J]. Stat Med,2021,40(25):5434-5452.
[17] Yang J,Ferreira T,Morris AP,et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits[J].?Nat Genet,2012,44(4):369-S3.
[18] Pierce BL,Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators[J].?Am J Epidemiol,2013,178(7):1177-1184.
[19] Bowden J. Misconceptions on the use of MR-Egger regression and the evaluation of the InSIDE assumption[J]. Int J Epidemiol,2017,46(6):2097-2099.
[20] Bowden J,Davey Smith G,Haycock PC,et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator[J].?Genet Epidemiol,2016,40(4):304-314.
[21] Verbanck M,Chen CY,Neale B,et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases[J].?Nat Genet,2018,50(5):693-698.
[22] Corrales-Medina VF,Alvarez KN,Weissfeld LA,et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease[J].?JAMA,2015,313(3):264-274.
[23] Ishani A,Collins AJ,Herzog CA,et al. Septicemia,access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study[J].?Kidney Int,2005,68(1):311-318.
[24] Kosyakovsky LB,Angriman F,Katz E,et al. Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis[J].?Intensive Care Med,2021,47(9):931-942.
[25] 谢飘,唐文芳,董波.心功能障碍与脓毒症治疗及预后的相关性研究进展[J].海南医学,2021,32(7):909-912.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(8):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(8):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(8):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(8):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(8):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(8):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(8):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]